This finding was further supported by the co-localization of GLP-1R with P504S/α-formyl-coenzyme A, a marker for prostate cancer.[12] Zheng et al conducted a controlled experimental study in rats and demonstrated the expression of GLP-1R in prostate tissues using immunohistochemistry and immunoblotting. Here, GLP1R is linked to prostate carcinoma.